Beneficial effect of melatonin treatment on inflammation, apoptosis and oxidative stress on pancreas of a senescence accelerated mice model

Mechanisms of Ageing and Development

Volumn 132, Issue 11-12, 2011, Pages 573-582

  Cuesta, Sara ^a   Kireev, Roman ^a   García, Cruz ^a   Forman, Katherine ^a   Escames, Germaine ^b   Vara, Elena ^a   Tresguerres, Jesús A F ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Aging; Cytokines; Inflammation; Melatonin; Pancreas; Senescence accelerated mouse

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MELATONIN; MESSENGER RNA; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PANCREATITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGING; ANIMALS; APOPTOSIS; BASE SEQUENCE; CYTOKINES; INFLAMMATION; MALE; MELATONIN; MICE; MODELS, ANIMAL; OXIDATIVE STRESS; PANCREAS; RNA, MESSENGER;

ANIMALIA; MUS;

EID: 84855871427     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2011.10.005     Document Type: Article

References (49)

1. Abraham N.G., Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic. Biol. Med. 2005, 39:1-25.
2. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. PNAS 1993, 90:7915-7922.
3. Arenzana-Seisdedos F., Turpin P., Rodriguez M., Thomas D., Hay R.T., Virelizier J.L., Dargemont C. Nuclear localization of IκBa promotes active transport of NF-κB from the nucleus to the cytoplasm. J. Cell Sci. 1997, 110:369-378.
4. Baeza I., Alvarado C., Alvarez P. Improvement of leucocyte functions in ovariectomised aged rats after treatment with growth hormone, melatonin, oestrogens or phyto-oestrogens. J. Reprod. Immunol. 2009, 80:70-79.
5. Beckmann J.S., Ye Y.Z., Anderson P.G., Chen J., Accavitti M.A., Tarpey M.M., White C.R. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe Seyler 1994, 375:81-88.
6. Chung H.Y., Kim H.J., Kim K.W. Molecular inflammation hypothesis of aging based on the anti-aging mechanism of calorie restriction. Microsc. Res. Technol. 2002, 59:264-272.
7. Cos S., Fernández R., Guezmes A. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res. 1998, 58:4383-4390.
8. Cuesta S., Kireev R., Forman K., García C., Escames G., Ariznavarreta C., Vara E., Tresguerres J.A. Melatonin improves inflammation processes in liver of senescence-accelerated prone male mice (SAMP8). Exp. Gerontol. 2010, 45(12):950-956.
9. Cuesta S., Kireev R., Forman K., García C., Ariznavarreta C., Vara E., Tresguerres J.A.F. Effect of GH treatment on pancreas inflammation, oxidative stress and apoptosis related to aging in SAMP8 mice. Rejuvenation Res. 2011, September 29 (Epub ahead of print).
10. De Fronzo R.A. Glucose intolerance of aging. Diabetes Care 1984, 4:493-513.
11. Deveraux Q.L., Roy N., Stennicke H.R., Van Arsdale T., Zhou Q., Srinivasula S.M. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 1998, 17:2215-2223.
12. Deveraux Q.L., Takahashi R., Salvesen G.S., Reed J.C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997, 388:300-304.
13. Donath M.Y., Storling J., Berchtold L.A., Billestrup N., Mandrup-Poulsen T. Cytokines and beta-cell biology: from concept to clinical translation. Endocr. Rev. 2008, 29(3):334-350.
14. Forman K., Vara E., García C., Kireev R., Cuesta S., Acuña-Castroviejo D., Tresguerres J.A. Beneficial effects of melatonin on cardiological alterations in a murine model of accelerated aging. J. Pineal Res. 2010, 49(3):312-320.
15. Harman D. The aging process. Medical sciences. Proc. Natl. Acad. Sci. U.S.A. 1981, 78(11):7124-7128.
16. Helenius M., Hänninen M., Lehtinen S.K. Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-κB transcription factor in mouse cardiac muscle. J. Mol. Cell Cardiol. 1996, 28:487-498.
17. Helenius M., Kyrylenko S., Vehviläinen P. Characterization of aging-associated up-regulation of constitutive nuclear factor-kappa B binding activity. Antioxid. Redox Signal. 2001, 3:147-156.
18. Hosokawa M. A higher oxidative status accelerates senescence and aggravates age-dependent disorders in SAMP strains of mice. Mech. Ageing Dev. 2002, 123:1553-1561.
19. Hu H., Forsey R.J., Blades T.J., Barratt M.E.J., Parmar P., Powell J.R. Antioxidants may contribute in the fight against aging: an in vitro model. Mech. Ageing Dev. 2000, 121:217-230.
20. Ito Y., Betsuyaku T., Moriyama C. Aging affects lipopolysaccharide-induced upregulation of heme oxygenase-1 in the lungs and alveolar macrophages. Biogerontology 2009, 10:173-180.
21. Kireev R.A., Tresguerres A.C., García C., Ariznavarreta C., Vara E., Tresguerres J.A. Melatonin is able to prevent the liver of old castrated female rats from oxidative and pro-inflammatory damage. J. Pineal Res. 2008, 45:394-402.
22. Kireev R.A., Tresguerres A.C., Garcia C., Borras C., Ariznavarreta C., Vara E., Vina J., Tresguerres J.A. Hormonal regulation of pro-inflammatory and lipid peroxidation processes in liver of old ovariectomized female rats. Biogerontology 2010, 11:229-243.
23. Lenardo M.J., Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989, 58:227-229.
24. Li Q.X., Xiong Z.Y., Hu B.P., Tian Z.J., Zhang H.F., Gou W.Y., Wang H.C., Gao F., Zhang Q.J. Aging-associated insulin resistance predisposes to hypertension and its reversal by exercise: the role of vascular vasorelaxation to insulin. Basic Res. Cardiol. 2009, 104:269-284.
25. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001, 25:402-408.
26. Matuszek Z., Reszka K.J., Chignell C.F. Reaction of melatonin and related indoles with hydroxyl radicals: ESR and spin trapping investigations. Free Radic. Biol. Med. 1997, 23:367-372.
27. Meites J., Goya R.G., Takahashi S. Why the neuroendocrine system is important in aging process. Exp. Gerontol. 1987, 22:1-5.
28. Michel T., Feron O. Nitric oxide synthases: which, where, how, and why?. J. Clin. Invest. 1997, 100:2146-2152.
29. Mori A., Utsumi K., Liu J., Hosokawa M. Oxidative damage in the senescence-accelerated mouse. Ann. N. Y. Acad. Sci. 1998, 854:239-250.
30. Morse D., Choi A.M. Heme oxygenase-1: the "emerging molecule" has arrived. Am. J. Respir. Cell Mol. Biol. 2002, 27:8-16.
31. Reaven E.P., Reaven G.N. Structure and function changes in the endocrine pancreas of aging rabbits with reference to the modulating effects of exercise and caloric restriction. J. Clin. Invest. 1981, 68:75-84.
32. Reiter R.J. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 1995, 9:526-533.
33. Reiter R.J. Aging and oxygen toxicity: relation to changes in melatonin. Age 1997, 20:201-213.
34. Reiter R.J. Oxidative damage in the central nervous system: protection by melatonin. Prog. Neurobiol. 1998, 56:359-384.
35. Reiter R.J., Craft C.M., Johnson J.E., King T.S., Richardson B.A., Vaughan G.M., Vaughan M.K. Age-associated reduction in nocturnal melatonin levels in female rats. Endocrinology 1981, 109:1295-1297.
36. Reiter R.J., Guerrero J.M., Garcia J.J., Acuña-Castroviejo D. Reactive oxygen intermediates, molecular damage and aging: relation to melatonin. Ann. N. Y. Acad. Sci. 1998, 854:410.
37. Rodríguez M.I., Escames G., López L.C. Chronic melatonin treatment reduces the age-dependent inflammatory process in senescence-accelerated mice. J. Pineal Res. 2007, 42:272-279.
38. Sasaki M., Jordan P., Joh T., Itoh M., Jenkins M., Pavlick K., Minagar A., Alexander S.J. Melatonin reduces TNF-α induced expression of MAdCAM-1 via inhibition of NF-kappaB. BMC Gastroenterol. 2002, 24:2-9.
39. Seta F., Bellner L., Rezzani R. Heme oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response. Am. J. Pathol. 2006, 169:1612-1623.
40. Song W., Kwak H.B., Kim J.H., Lawler J.M. Exercise training modulates the nitric oxide synthase profile in skeletal muscle from old rats. J. Gerontol. A Biol. Sci. Med. Sci. 2009, 64:540-549.
41. Stoclet J.C., Muller B., Gyorgy The inducible nitric oxide synthase in vascular and cardiac tissue. Eur. J. Pharmacol. 1999, 375:139-155.
42. Takeda T. Senescence-accelerated mouse (SAM): a biogerontological resource in aging research. Neurobiol. Aging 1999, 20:105-110.
43. Takeda T., Hosokawa M., Higuchi K. Senescence-accelerated mouse (SAM): a novel murine model of senescence. Exp. Gerontol. 1997, 32:105-109.
44. Tan D.X., Manchester L.C., Reiter R.J., Plummer B.F., Hardies L.J., Weintraub S.T., Vijayalaxmi, Shepherd A.M. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation. Biochem. Biophys. Res. Commun. 1998, 253:614-620.
45. Tan D.X., Reiter R.J., Chen L.D., Poeggeler B., Manchester L.C., Barlow-Walden L.R. Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 1994, 15:215-218.
46. Tha K.K., Okuma Y., Miyazaki H. Changes in expressions of proinflammatory cytokines IL-1beta, TNF-alpha and IL-6 in the brain of senescence accelerated mouse (SAM) P8. Brain Res. 2000, 885:25-31.
47. Tresguerres J.A.F., Kireev R.A., Tresguerres A.C.F., Borras C., Vara E., Ariznavarreta C. Molecular mechanisms involved in the hormonal prevention of aging in the rat. J. Steroid Biochem. Mol. Biol. 2008, 108:318-326.
48. Valen G., Yan Z.Q., Hansson G.K. Nuclear factor kappa-B and the heart. J. Am. Coll. Cardiol. 2001, 38:307-314.
49. Zhang Y., Herman B. Apoptosis and successful aging. Mech. Ageing Dev. 2002, 123:563-565.